@FierceBiotech: Sanofi offers promising survival data on prostate cancer drug cabazitaxel. Article | Follow @FierceBiotech
@JohnCFierce: Yesterday I calculated that I have written more than two million words on biotech. There has to be a cure.... | Follow @JohnCFierce
> YM BioSciences, announced today that it is raising approximately $15 million in a registered direct offering of units at a price of $1.20 per unit. YM release
> Waltham-based Thermo Fisher Scientific, which has offices in Central Massachusetts, has completed its acquisition of Woburn-based Finnzymes. Finnzymes, which makes tools for scientific experimentation, will join Thermo Fisher's analytical technologies department. According to Thermo Fisher, Finnzymes generated revenues of about $20 million in 2009. Story
> La Jolla Pharmaceutical and Adamis Pharmaceuticals Corporation have agreed to terminate their merger agreement relating to the proposed merger of the two companies. La Jolla release
> Anthera Pharmaceuticals, a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the completion of its initial public offering of 6 million shares of common stock at a price of $7.00 per share. Anthera release
And Finally... The Wall Street Journal gets a tour of J. Craig Venter's his new home in La Jolla, CA. Article